Related Experiment Video
Updated: Feb 12, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in
Luyan Mu1,2, Yu Long1,3, Changlin Yang3
1The Fourth Section of Department of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Abstract:
Background: Malignant gliomas are heterogeneous brain tumors with the potential for aggressive disease progression, as influenced by suppressive immunoediting. Given the success and enhanced potential of immune-checkpoint inhibitors in immunotherapy, we focused on the connections between genetic alterations affected by IDH1 mutations and immunological landscape changes and PDL-1 expression in gliomas. Methods: Paired surgically resected tumors from lower-grade gliomas (LGGs) and glioblastomas (GBM) were investigated, and a genetic analysis of patients' primary tumor samples culled from TCGA datasets was performed. Results: The results demonstrate that when compared with IDH1-mutant tumors, IDH1 wildtype tumors represent an immunosuppression landscape and elevated levels of PD-L1 expression. DNA hypo-methylation of the PD-L1 gene, as well as high gene and protein expressions, were observed in the wildtype tumors. We also found that quantitative levels of IDH1 mutant proteins were positively associated with recurrence-free survival (RFS). A key product of the IDH1 mutation (2-hydroxyglutarate) was found to transiently increase DNA methylation and suppress PD-L1 expression. Conclusions: IDH1 mutations impact the immune landscape of gliomas by affecting immune infiltrations and manipulating checkpoint ligand PD-L1 expression. Applications of immune checkpoint inhibitors may be beneficial for chemoradiation-insensitive IDH1-wildtype gliomas.
Insights
IDH1 mutations in gliomas influence the tumor immune microenvironment and PD-L1 expression. IDH1 wildtype gliomas show suppressed immunity and higher PD-L1, suggesting potential benefit from immune checkpoint inhibitors.
Area of Science:
- Neuro-oncology
- Immunology
- Cancer Genetics
Background:
- Malignant gliomas are aggressive brain tumors influenced by immunoediting.
- Immune-checkpoint inhibitors show promise in cancer immunotherapy.
- Understanding IDH1 mutations' role in glioma immunity is crucial.
Purpose of the Study:
- To investigate the link between IDH1 mutations, immune landscape, and PD-L1 expression in gliomas.
- To explore the impact of IDH1 status on tumor immunity and treatment response.
Main Methods:
- Analysis of paired tumor samples from lower-grade gliomas (LGGs) and glioblastomas (GBMs).
- Genetic analysis of glioma patient samples from The Cancer Genome Atlas (TCGA) database.
- Assessment of PD-L1 gene and protein expression and DNA methylation patterns.
Main Results:
- IDH1 wildtype gliomas exhibit an immunosuppressive landscape and elevated PD-L1 expression compared to IDH1-mutant gliomas.
- IDH1 wildtype tumors show PD-L1 gene hypomethylation and increased gene/protein expression.
- IDH1 mutations correlate with increased recurrence-free survival (RFS) and 2-hydroxyglutarate suppresses PD-L1.
Conclusions:
- IDH1 mutations significantly alter glioma immune infiltration and PD-L1 expression.
- Immune checkpoint inhibitors may offer therapeutic benefits for IDH1 wildtype gliomas resistant to chemoradiation.
More Related Videos
07:04Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Spontaneous and Induced Mutations
Viral Mutations
Role of Affect in Interpersonal Attraction
Mutation, Gene Flow, and Genetic Drift